Mission
RIGHT’s main objectives are: 1) to promote the development of new therapies and novel vaccines in the area of HIV/AIDS;
2) to field preclinical research and clinical trials to facilitate transfer of laboratory biomedical research into
new therapies for patients, and
3) to drive innovative basic research that ensures the widest cooperation possible within the international
scientific community.
In order to expand scientific research activities and promote the transfer of laboratory results into clinical practice, RIGHT has spun off two for-profit companies, the Hungarian/US biotech company Genetic Immunity working on nanomedicine-based plasmid DNA therapeutic vaccines and ViroStatics, an Italian company devoted to the discovery and development of small molecules for treating HIV/AIDS and other chronic conditions.
